Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schmid

Showing results (461-470 of 629) with videos related to

Pageof 63
Sort By:
European Urology Focus|February 25, 2020
Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study GroupRodrigo Suarez-Ibarrola, Friedemann Zengerling, Marlene Haccius, et al.
Future Oncology (London, England)|November 16, 2022
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancerSara A Hurvitz, Thomas Bachelot, Giampaolo Bianchini, et al.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast CancerKomal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
Allergy|January 19, 2026
The EAACI-UEMS Knowledge Examination: Certifying Standards in Allergy and Clinical Immunology Across EuropeKnut Brockow, Ileana M Ghiordanescu, Chiara Tontini, et al.
Influenza and Other Respiratory Viruses|July 12, 2016
Rapid detection and subtyping of European swine influenza viruses in porcine clinical samples by haemagglutinin- and neuraminidase-specific tetra- and triplex real-time RT-PCRsDinah Henritzi, Na Zhao, Elke Starick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLCDavid R Spigel, Jamie E Chaft, Scott Gettinger, et al.
Cancer Medicine|June 12, 2020
Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS studySalome Adam, Eva Martin-Diener, Bertrand Camey, et al.
The Lancet. Oncology|December 2, 2019
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trialPeter Schmid, Hope S Rugo, Sylvia Adams, et al.
BJU International|January 23, 2020
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registryPascal Viktorin-Baier, Paul M Putora, Hans-Peter Schmid, et al.
Plos One|May 23, 2012
High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brainMartin C Herzig, Michael Bidinosti, Tatjana Schweizer, et al.
Pageof 63

Showing results (461-470 of 629) with videos related to

Sort By:
Pageof 63
European Urology Focus|February 25, 2020
Adherence to European Association of Urology and National Comprehensive Cancer Network Guidelines Criteria for Inguinal and Pelvic Lymph Node Dissection in Penile Cancer Patients-A Survey Assessment in German-speaking Countries on Behalf of the European Prospective Penile Cancer Study GroupRodrigo Suarez-Ibarrola, Friedemann Zengerling, Marlene Haccius, et al.
Future Oncology (London, England)|November 16, 2022
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancerSara A Hurvitz, Thomas Bachelot, Giampaolo Bianchini, et al.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Inavolisib in <i>PIK3CA</i>-Mutated Advanced Breast CancerKomal L Jhaveri, Seock-Ah Im, Cristina Saura, et al.
Allergy|January 19, 2026
The EAACI-UEMS Knowledge Examination: Certifying Standards in Allergy and Clinical Immunology Across EuropeKnut Brockow, Ileana M Ghiordanescu, Chiara Tontini, et al.
Influenza and Other Respiratory Viruses|July 12, 2016
Rapid detection and subtyping of European swine influenza viruses in porcine clinical samples by haemagglutinin- and neuraminidase-specific tetra- and triplex real-time RT-PCRsDinah Henritzi, Na Zhao, Elke Starick, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLCDavid R Spigel, Jamie E Chaft, Scott Gettinger, et al.
Cancer Medicine|June 12, 2020
Health-related quality of life in long-term prostate cancer survivors after nerve-sparing and non-nerve-sparing radical prostatectomy-Results from the multiregional PROCAS studySalome Adam, Eva Martin-Diener, Bertrand Camey, et al.
The Lancet. Oncology|December 2, 2019
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trialPeter Schmid, Hope S Rugo, Sylvia Adams, et al.
BJU International|January 23, 2020
Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registryPascal Viktorin-Baier, Paul M Putora, Hans-Peter Schmid, et al.
Plos One|May 23, 2012
High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brainMartin C Herzig, Michael Bidinosti, Tatjana Schweizer, et al.
Pageof 63